CN108530361A - A kind of synthesis technology of 5- [2- (3,5- Dimethoxyphenyls) ethyl] -1H- pyrazoles -3- amine - Google Patents
A kind of synthesis technology of 5- [2- (3,5- Dimethoxyphenyls) ethyl] -1H- pyrazoles -3- amine Download PDFInfo
- Publication number
- CN108530361A CN108530361A CN201810474615.6A CN201810474615A CN108530361A CN 108530361 A CN108530361 A CN 108530361A CN 201810474615 A CN201810474615 A CN 201810474615A CN 108530361 A CN108530361 A CN 108530361A
- Authority
- CN
- China
- Prior art keywords
- ethyl
- dimethoxyphenyl
- amine
- reaction
- pyrazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003786 synthesis reaction Methods 0.000 title claims abstract description 13
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 title claims description 8
- 238000005516 engineering process Methods 0.000 title claims description 4
- 238000006243 chemical reaction Methods 0.000 claims abstract description 34
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 30
- 238000000034 method Methods 0.000 claims abstract description 28
- QKEFSZDRDPDTTE-UHFFFAOYSA-N 5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-amine Chemical compound COC1=CC(OC)=CC(CCC=2NN=C(N)C=2)=C1 QKEFSZDRDPDTTE-UHFFFAOYSA-N 0.000 claims abstract description 20
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 18
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims abstract description 10
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000003054 catalyst Substances 0.000 claims abstract description 8
- 239000003960 organic solvent Substances 0.000 claims abstract description 7
- -1 2-(3,5-dimethoxyphenyl) ethyl Chemical group 0.000 claims abstract description 5
- FKRCODPIKNYEAC-UHFFFAOYSA-N propionic acid ethyl ester Natural products CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 claims abstract description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 13
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical group [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 9
- 238000004440 column chromatography Methods 0.000 claims description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 4
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 claims description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 3
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 claims description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 2
- 235000021050 feed intake Nutrition 0.000 claims 1
- 239000000047 product Substances 0.000 abstract description 10
- 230000035484 reaction time Effects 0.000 abstract description 10
- VRQMAABPASPXMW-HDICACEKSA-N AZD4547 Chemical compound COC1=CC(OC)=CC(CCC=2NN=C(NC(=O)C=3C=CC(=CC=3)N3C[C@@H](C)N[C@@H](C)C3)C=2)=C1 VRQMAABPASPXMW-HDICACEKSA-N 0.000 abstract description 5
- 238000007039 two-step reaction Methods 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 2
- 238000009776 industrial production Methods 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 239000000543 intermediate Substances 0.000 abstract 2
- 238000007363 ring formation reaction Methods 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
- 238000010189 synthetic method Methods 0.000 abstract 1
- 239000002351 wastewater Substances 0.000 abstract 1
- BVUPVBRNFNZEFT-UHFFFAOYSA-N ethyl 2-(3,5-dimethoxyphenyl)propanoate Chemical compound CCOC(=O)C(C)C1=CC(OC)=CC(OC)=C1 BVUPVBRNFNZEFT-UHFFFAOYSA-N 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- TWTSUOMTAJVXJJ-UHFFFAOYSA-N COC=1C=C(C=C(C1)OC)CCC(CC#N)=C=O Chemical compound COC=1C=C(C=C(C1)OC)CCC(CC#N)=C=O TWTSUOMTAJVXJJ-UHFFFAOYSA-N 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- JVVRJMXHNUAPHW-UHFFFAOYSA-N 1h-pyrazol-5-amine Chemical compound NC=1C=CNN=1 JVVRJMXHNUAPHW-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229940125829 fibroblast growth factor receptor inhibitor Drugs 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
本发明属于医药化工领域,具体涉及一种AZD4547关键中间体5‑[2‑(3,5‑二甲氧基苯基)乙基]‑1H‑吡唑‑3‑胺的合成新工艺。其以2‑(3,5‑二甲氧基苯基)丙酸乙酯为起始原料,在碱性催化剂、有机溶剂存在条件下与乙腈反应,后所得产物在浓硫酸条件下与水合肼环合,得目标产物5‑[2‑(3,5‑二甲氧基苯基)乙基]‑1H‑吡唑‑3‑胺。本发明的提供的5‑[2‑(3,5‑二甲氧基苯基)乙基]‑1H‑吡唑‑3‑胺的合成方法与现有技术相比,大大缩短了反应时间,产品收率更高,并且两步反应之间不存在纯化中间体的过程,缩短了反应周期,且减少了废水排放,适合于工业化大生产。The invention belongs to the field of medicine and chemical industry, and specifically relates to a new synthesis process of AZD4547 key intermediate 5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazole-3-amine. It takes 2-(3,5-dimethoxyphenyl) ethyl propionate as the starting material, reacts with acetonitrile under the condition of presence of basic catalyst and organic solvent, and then reacts the obtained product with hydrazine hydrate under the condition of concentrated sulfuric acid Cyclization to obtain the target product 5-[2-(3,5-dimethoxyphenyl) ethyl]-1H-pyrazole-3-amine. Compared with the prior art, the synthetic method of 5-[2-(3,5-dimethoxyphenyl) ethyl]-1H-pyrazole-3-amine provided by the present invention greatly shortens the reaction time, The product yield is higher, and there is no process of purifying intermediates between the two-step reactions, which shortens the reaction cycle and reduces waste water discharge, and is suitable for large-scale industrial production.
Description
技术领域technical field
本发明属于医药化工领域,具体涉及一种AZD4547关键中间体5-[2-(3,5-二甲氧基苯基)乙基]-1H-吡唑-3-胺的合成新工艺。The invention belongs to the field of medicine and chemical industry, and specifically relates to a new synthesis process of AZD4547 key intermediate 5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazole-3-amine.
背景技术Background technique
AZD4547是由阿斯利康公司研发,用于胃癌、食管癌、乳腺癌等非小细胞肺癌治疗的选择性FGFR抑制剂,目前尚处于二期临床研究中,其结构式如下所示:AZD4547 is a selective FGFR inhibitor developed by AstraZeneca for the treatment of gastric cancer, esophageal cancer, breast cancer and other non-small cell lung cancers. It is currently in phase II clinical research. Its structural formula is as follows:
目前,关于AZD4547关键中间体5-[2-(3,5-二甲氧基苯基)乙基]-1H-吡唑-3-胺的合成文献较少,Norman等人在Journal of Medicinal Chemistry,55(11),5003-5012,2012中报道了以2-(3,5-二甲氧基苯基)丙酸乙酯为原料,在氢化钠作用下与乙腈反应生成5-(3,5-二甲氧基苯基)-3-羰基-戊腈,再与水合肼环合得到目标化合物,两步反应收率分别为44%和42%,且第一步需要柱层析得到中间体5-(3,5-二甲氧基苯基)-3-羰基-戊腈,另外此方法存在反应液易变成胶状,难以搅拌,且后处理时乳化严重,导致分离纯化困难、收率较低等问题。At present, there are few synthetic documents about the key intermediate 5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-amine of AZD4547, and Norman et al. , 55(11), 5003-5012, 2012 reported that 2-(3,5-dimethoxyphenyl) ethyl propionate was used as a raw material to react with acetonitrile under the action of sodium hydride to generate 5-(3, 5-dimethoxyphenyl)-3-carbonyl-valeronitrile, and then cyclized with hydrazine hydrate to obtain the target compound, the two-step reaction yields were 44% and 42%, and the first step required column chromatography to obtain the intermediate 5-(3,5-dimethoxyphenyl)-3-carbonyl-valeronitrile, in addition, the reaction solution in this method tends to become colloidal, difficult to stir, and the emulsification is serious during post-treatment, resulting in difficulties in separation and purification. issues such as low yields.
因此亟需开发一种操作简单、收率高、产品纯度高的5-[2-(3,5-二甲氧基苯基)乙基]-1H-吡唑-3-胺合成新工艺。Therefore, it is urgent to develop a new synthesis process of 5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-amine with simple operation, high yield and high product purity.
发明内容Contents of the invention
有鉴于此,本发明的目的在于提供一种5-[2-(3,5-二甲氧基苯基)乙基]-1H-吡唑-3-胺的合成新工艺,其反应耗时短、操作简单。In view of this, the object of the present invention is to provide a kind of synthetic new technique of 5-[2-(3,5-dimethoxyphenyl) ethyl]-1H-pyrazol-3-amine, and its reaction is time-consuming Short and easy to operate.
为实现上述目的,本发明的技术方案为:To achieve the above object, the technical solution of the present invention is:
一种5-[2-(3,5-二甲氧基苯基)乙基]-1H-吡唑-3-胺的合成新工艺,其包括以下步骤:A new synthesis process of 5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-amine, which comprises the following steps:
1)将非质子性有机溶剂降温至-50~-100℃,加入碱性催化剂、乙腈和2-(3,5-二甲氧基苯基)丙酸乙酯,后保持-50~-100℃下反应2~5小时;1) Cool down the aprotic organic solvent to -50~-100℃, add basic catalyst, acetonitrile and ethyl 2-(3,5-dimethoxyphenyl) propionate, and keep it at -50~-100℃ Reaction at ℃ for 2 to 5 hours;
2)向步骤1)的溶液中加入浓硫酸、水合肼的非质子性有机溶剂,升温至50-100℃反应2~5小时,生成5-[2-(3,5-二甲氧基苯基)乙基]-1H-吡唑-3-胺。2) Add concentrated sulfuric acid and an aprotic organic solvent of hydrazine hydrate to the solution in step 1), heat up to 50-100°C and react for 2-5 hours to generate 5-[2-(3,5-dimethoxybenzene Base) ethyl] -1H-pyrazol-3-amine.
本发明步骤1)中使用碱性催化剂替换现有技术中使用的氢化钠,使用的溶剂也不同,并探索了反应条件,在温度为-50~-100℃时,保温2~5小时可完成反应,且反应后将反应液直接进行步骤2)的反应。背景技术的需要回流加热,且反应时间为18小时,并在步骤1)反应后需要过柱、纯化中间产物5-(3,5-二甲氧基苯基)-3-羰基-戊腈,反应时间长且操作更复杂。In step 1) of the present invention, a basic catalyst is used to replace the sodium hydride used in the prior art, and the solvent used is also different, and the reaction conditions have been explored. When the temperature is -50 ~ -100 ° C, the insulation can be completed for 2 ~ 5 hours reaction, and after the reaction, the reaction solution is directly carried out to the reaction of step 2). The background technology requires reflux heating, and the reaction time is 18 hours, and after the reaction in step 1), it is necessary to pass through the column and purify the intermediate product 5-(3,5-dimethoxyphenyl)-3-carbonyl-valeronitrile, The reaction time is long and the operation is more complicated.
本发明的步骤2)在步骤1)的反应液基础上直接进行。经过试验、摸索,使用了浓硫酸,强酸性条件下进行,提高了反应选择性,目标产物的收率更高。Step 2) of the present invention is carried out directly on the basis of the reaction liquid of step 1). After experimentation and exploration, concentrated sulfuric acid was used and carried out under strong acidic conditions, which improved the reaction selectivity and the yield of the target product was higher.
步骤2)使用的溶剂为非质子性溶剂,反应条件为50-100℃反应2~5小时,后续采用层析柱层析,产品收率可达60%以上。而背景技术溶剂为乙醇,需要回流加热,且反应时间24小时,反应液易变成胶状,后处理时乳化严重,收率仅为42%。The solvent used in step 2) is an aprotic solvent, and the reaction condition is 50-100°C for 2-5 hours, followed by column chromatography, and the product yield can reach more than 60%. However, the solvent in the background technology is ethanol, which needs to be refluxed and heated, and the reaction time is 24 hours, the reaction liquid is easy to become gelatinous, and the emulsification is serious during the post-treatment, and the yield is only 42%.
因此,本发明的工艺通过使用浓硫酸、碱性催化剂以及溶剂的选择、过层析柱顺序的调整,解决了5-[2-(3,5-二甲氧基苯基)乙基]-1H-吡唑-3-胺的合成反应时间长、收率低、操作复杂的问题。本发明的工艺中,反应时间大幅缩短、收率提高,且两步反应在同一容器中进行,中间没有对中间产物的过柱、纯化过程,操作简单。Therefore, technique of the present invention solves 5-[2-(3,5-dimethoxyphenyl) ethyl]- The synthesis of 1H-pyrazol-3-amine has the problems of long reaction time, low yield and complicated operation. In the process of the present invention, the reaction time is greatly shortened, the yield is increased, and the two-step reaction is carried out in the same container, there is no process of column passing and purification of the intermediate product, and the operation is simple.
作为优选的方案,步骤1)所述碱性催化剂为正丁基锂、叔丁基锂、叔丁醇钾、二异丙基氨基锂、氢氧化钾的一种或多种。As a preferred solution, the basic catalyst in step 1) is one or more of n-butyllithium, tert-butyllithium, potassium tert-butoxide, lithium diisopropylamide, and potassium hydroxide.
进一步,优选为正丁基锂、叔丁基锂。Further, n-butyllithium and tert-butyllithium are preferred.
作为优选的方案,步骤1)所述非质子性有机溶剂为四氢呋喃、二氧六环、正己烷、环己烷的一种或多种。As a preferred solution, the aprotic organic solvent in step 1) is one or more of tetrahydrofuran, dioxane, n-hexane, and cyclohexane.
进一步,优选为四氢呋喃。Further, tetrahydrofuran is preferred.
作为优选的方案,步骤1)所述保温反应时间为3-4小时。As a preferred scheme, the heat preservation reaction time of step 1) is 3-4 hours.
作为优选的方案,步骤1)所述反应温度为-70~-80℃。As a preferred scheme, the reaction temperature in step 1) is -70 to -80°C.
作为优选的方案,步骤1)所述碱性催化剂、乙腈、2-(3,5-二甲氧基苯基)丙酸乙酯投料的摩尔比为1.5-2.5:0.8-1.2:1.0。As a preferred solution, the molar ratio of the basic catalyst, acetonitrile, and ethyl 2-(3,5-dimethoxyphenyl)propionate in step 1) is 1.5-2.5:0.8-1.2:1.0.
进一步,优选为2.0:1.0:1.0。Further, it is preferably 2.0:1.0:1.0.
作为优选的方案,步骤2)所述反应温度为75~90℃。As a preferred solution, the reaction temperature in step 2) is 75-90°C.
作为优选的方案,步骤2)所述浓硫酸为质量分数大于75%的硫酸溶液。As a preferred solution, the concentrated sulfuric acid in step 2) is a sulfuric acid solution with a mass fraction greater than 75%.
进一步,优选为质量分数为98%的硫酸溶液。Further, it is preferably a sulfuric acid solution with a mass fraction of 98%.
作为优选的方案,步骤2)所述浓硫酸、水合肼与步骤1)所述2-(3,5-二甲氧基苯基)丙酸乙酯投料的摩尔比为0.9-1.1:1.3-1.8:1.0。As a preferred scheme, the molar ratio of the concentrated sulfuric acid, hydrazine hydrate described in step 2) and 2-(3,5-dimethoxyphenyl) ethyl propionate in step 1) is 0.9-1.1:1.3- 1.8:1.0.
进一步,优选为1.0:1.4-1.6:1。Further, it is preferably 1.0:1.4-1.6:1.
作为优选的方案,步骤2)所述反应时间为3-4小时。As a preferred scheme, the reaction time in step 2) is 3-4 hours.
作为优选的方案,步骤2)后包含后处理过程,具体为:步骤2)的反应液浓缩并经层析柱层析,得产物5-[2-(3,5-二甲氧基苯基)乙基]-1H-吡唑-3-胺。As a preferred solution, step 2) includes a post-treatment process, specifically: the reaction solution in step 2) is concentrated and subjected to column chromatography to obtain the product 5-[2-(3,5-dimethoxyphenyl )ethyl]-1H-pyrazol-3-amine.
本发明的目的之二在于提供一种目的一的工艺制备的5-[2-(3,5-二甲氧基苯基)乙基]-1H-吡唑-3-胺。The second object of the present invention is to provide 5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-amine prepared by the process of the first object.
采用本发明的工艺制备5-[2-(3,5-二甲氧基苯基)乙基]-1H-吡唑-3-胺,反应时间缩短、收率提高,进而能够降低产品的成本。并且本发明的工艺操作简单,适用于工业化大生产。对于进一步制备AZD4547有重要意义。The preparation of 5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-amine by the process of the present invention shortens the reaction time and improves the yield, thereby reducing the cost of the product . Moreover, the process of the invention is simple to operate and is suitable for large-scale industrial production. It is of great significance for the further preparation of AZD4547.
本发明的有益效果在于:The beneficial effects of the present invention are:
1)本发明提供的5-[2-(3,5-二甲氧基苯基)乙基]-1H-吡唑-3-胺的合成反应时间大幅缩短,操作更为简单,适于工业化大生产。1) The synthesis reaction time of 5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-amine provided by the present invention is greatly shortened, the operation is simpler, and it is suitable for industrialization Big production.
2)本发明的工艺中,两步反应在同一容器中进行,将过柱、纯化过程放置于反应的后处理,解决了原有的反应液易变成胶状、后处理时乳化严重的问题,并简化了操作过程。2) In the process of the present invention, the two-step reaction is carried out in the same container, and the column passing and purification process are placed in the post-treatment of the reaction, which solves the problem that the original reaction solution easily becomes gelatinous and the emulsification is serious during post-treatment , and simplify the operation process.
3)本发明的工艺提高5-[2-(3,5-二甲氧基苯基)乙基]-1H-吡唑-3-胺的收率至60%以上,且产物纯度高,降低生产成本。3) The process of the present invention improves the yield of 5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-amine to more than 60%, and the product has high purity and reduces Cost of production.
具体实施方式Detailed ways
以下将对本发明的优选实施例进行详细描述。优选实施例中未注明具体条件的实验方法,通常按照常规条件,所举实施例是为了更好地对本发明的内容进行说明,但并不是本发明的内容仅限于所举实施例。所以熟悉本领域的技术人员根据上述发明内容对实施方案进行非本质的改进和调整,仍属于本发明的保护范围。Preferred embodiments of the present invention will be described in detail below. The experimental method that does not indicate specific conditions in the preferred embodiment is usually according to conventional conditions, and the examples given are to better illustrate the content of the present invention, but the content of the present invention is not limited to the examples given. Therefore, non-essential improvements and adjustments to the implementation by those skilled in the art based on the content of the invention above still fall within the protection scope of the present invention.
实施例1 5-[2-(3,5-二甲氧基苯基)乙基]-1H-吡唑-3-胺合成方案1Example 1 5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-amine Synthesis Scheme 1
1)将10mL无水四氢呋喃降温至-78℃,加入1.01mL(2.52mmol)正丁基锂(2.5mol/L的正己烷溶液),滴加66.5μL乙腈。滴加完毕,再滴加300mg2-(3,5-二甲氧基苯基)丙酸乙酯的四氢呋喃溶液。滴毕,-78℃下反应3h。1) Cool 10 mL of anhydrous tetrahydrofuran to -78°C, add 1.01 mL (2.52 mmol) of n-butyllithium (2.5 mol/L n-hexane solution), and dropwise add 66.5 μL of acetonitrile. After the dropwise addition, 300 mg of ethyl 2-(3,5-dimethoxyphenyl)propionate in tetrahydrofuran was added dropwise. After dropping, react at -78°C for 3h.
2)TLC监测反应完全后,加入68.5μL质量分数为98%的浓硫酸。再缓慢滴加115μL(1.89mmol)水合肼的四氢呋喃溶液,滴加完毕,转至80℃下反应3h。2) After the completion of the reaction was monitored by TLC, 68.5 μL of concentrated sulfuric acid with a mass fraction of 98% was added. Then slowly add 115 μL (1.89 mmol) of a tetrahydrofuran solution of hydrazine hydrate dropwise. After the dropwise addition is complete, transfer to 80° C. for 3 h of reaction.
3)将反应液浓缩后直接经层析柱层析得黄色固体156mg,产率为50.1%。3) After the reaction solution was concentrated, 156 mg of a yellow solid was directly obtained by column chromatography, and the yield was 50.1%.
实施例2 5-[2-(3,5-二甲氧基苯基)乙基]-1H-吡唑-3-胺合成方案2Example 2 5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-amine Synthesis Scheme 2
1)将10mL无水二氧六环降温至-70℃,加入1.01mL(2.52mmol)正丁基锂(2.5mol/L的正己烷溶液),滴加66.5μL乙腈。滴加完毕,再滴加300mg2-(3,5-二甲氧基苯基)丙酸乙酯。滴毕,-60℃下反应3h。1) Cool 10 mL of anhydrous dioxane to -70°C, add 1.01 mL (2.52 mmol) of n-butyllithium (2.5 mol/L n-hexane solution), and dropwise add 66.5 μL of acetonitrile. After the dropwise addition, 300 mg of ethyl 2-(3,5-dimethoxyphenyl)propionate was added dropwise. After dropping, react at -60°C for 3h.
2)TLC监测反应完全后,加入68.5μL质量分数为98%的浓硫酸。再缓慢滴加115μL(1.89mmol)水合肼的二氧六环溶液,滴加完毕,转至60℃下反应3h。2) After the completion of the reaction was monitored by TLC, 68.5 μL of concentrated sulfuric acid with a mass fraction of 98% was added. Then, 115 μL (1.89 mmol) of hydrazine hydrate in dioxane solution was slowly added dropwise, and after the addition was completed, the reaction was carried out at 60° C. for 3 h.
3)将反应液浓缩后直接经层析柱层析得黄色固体147mg,产率为48%。3) After the reaction solution was concentrated, 147 mg of a yellow solid was directly obtained by column chromatography, with a yield of 48%.
实施例3 5-[2-(3,5-二甲氧基苯基)乙基]-1H-吡唑-3-胺合成方案3Example 3 5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-amine Synthesis Scheme 3
1)将10mL无水正己烷降温至-80℃,加入1.01mL(2.52mmol)正丁基锂(2.5mol/L的正己烷溶液),滴加66.5μL乙腈。滴加完毕,再滴加300mg 2-(3,5-二甲氧基苯基)丙酸乙酯。滴毕,-95℃下反应3h。1) Cool 10 mL of anhydrous n-hexane to -80°C, add 1.01 mL (2.52 mmol) of n-butyllithium (2.5 mol/L n-hexane solution), and dropwise add 66.5 μL of acetonitrile. After the dropwise addition, 300 mg of ethyl 2-(3,5-dimethoxyphenyl)propionate was added dropwise. After dropping, react at -95°C for 3h.
2)TLC监测反应完全后,加入68.5μL质量分数为98%的浓硫酸。再缓慢滴加115μL(1.89mmol)水合肼的的正己烷溶液,滴加完毕,转至90℃下反应3h。2) After the completion of the reaction was monitored by TLC, 68.5 μL of concentrated sulfuric acid with a mass fraction of 98% was added. Then, 115 μL (1.89 mmol) of hydrazine hydrate in n-hexane was slowly added dropwise. After the dropwise addition was completed, the reaction was carried out at 90° C. for 3 h.
3)将反应液浓缩后直接经层析柱层析得黄色固体143.8mg,产率为46%。3) After the reaction solution was concentrated, 143.8 mg of a yellow solid was directly obtained by column chromatography, and the yield was 46%.
实施例4 5-[2-(3,5-二甲氧基苯基)乙基]-1H-吡唑-3-胺合成方案4Example 4 5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-amine Synthesis Scheme 4
1)将10mL四氢呋喃降温至-70℃,加入200mg(0.840mmol)2-(3,5-二甲氧基苯基)丙酸乙酯,使溶于四氢呋喃中,加入188.35mg叔丁醇钾,再加入44.3μL乙腈,-70℃搅拌反应3h。1) Cool 10mL of tetrahydrofuran to -70°C, add 200mg (0.840mmol) of ethyl 2-(3,5-dimethoxyphenyl) propionate, dissolve in tetrahydrofuran, add 188.35mg of potassium tert-butoxide, Then 44.3 μL of acetonitrile was added, and the reaction was stirred at -70°C for 3 h.
2)再加入45.7μL质量分数为98%的浓硫酸,缓慢滴加76.3μL(1.26mmol)水合肼的四氢呋喃溶液,滴加完毕,转至80℃下反应3h。2) Add 45.7 μL of concentrated sulfuric acid with a mass fraction of 98%, slowly add 76.3 μL (1.26 mmol) of hydrazine hydrate in tetrahydrofuran solution dropwise, after the dropwise addition is complete, transfer to 80° C. for 3 h.
3)将反应液浓缩后直接经层析柱层析得黄白色固体128mg,产率61%。3) After the reaction solution was concentrated, 128 mg of a yellow-white solid was directly obtained by column chromatography, and the yield was 61%.
对产物进行核磁共振氢谱分析,结果如下:The product is carried out proton nuclear magnetic resonance spectrum analysis, and the results are as follows:
m.p.110~112℃。1H-NMR(DMSO-d6,400MHz),δ:6.62(br s,2H),6.38(d,J=2.0Hz,2H),6.32(t,J=2.0Hz,1H),5.45(s,1H),3.78(s,6H),2.86(s,4H)。mp110~112℃. 1 H-NMR (DMSO-d6, 400MHz), δ: 6.62(br s, 2H), 6.38(d, J=2.0Hz, 2H), 6.32(t, J=2.0Hz, 1H), 5.45(s, 1H), 3.78(s,6H), 2.86(s,4H).
由此,本发明开发了一种操作简单、收率高、产品纯度高,且适于工业化大生产的5-[2-(3,5-二甲氧基苯基)乙基]-1H-吡唑-3-胺合成新工艺。Thus, the present invention has developed a 5-[2-(3,5-dimethoxyphenyl)ethyl]-1H- A new process for the synthesis of pyrazol-3-amine.
最后说明的是,以上实施例仅用以说明本发明的技术方案而非限制,尽管参照较佳实施例对本发明进行了详细说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者等同替换,而不脱离本发明技术方案的宗旨和范围,其均应涵盖在本发明的权利要求范围当中。Finally, it is noted that the above embodiments are only used to illustrate the technical solutions of the present invention without limitation. Although the present invention has been described in detail with reference to the preferred embodiments, those of ordinary skill in the art should understand that the technical solutions of the present invention can be carried out Modifications or equivalent replacements without departing from the spirit and scope of the technical solution of the present invention shall be covered by the claims of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810474615.6A CN108530361A (en) | 2018-05-17 | 2018-05-17 | A kind of synthesis technology of 5- [2- (3,5- Dimethoxyphenyls) ethyl] -1H- pyrazoles -3- amine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810474615.6A CN108530361A (en) | 2018-05-17 | 2018-05-17 | A kind of synthesis technology of 5- [2- (3,5- Dimethoxyphenyls) ethyl] -1H- pyrazoles -3- amine |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108530361A true CN108530361A (en) | 2018-09-14 |
Family
ID=63472117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810474615.6A Pending CN108530361A (en) | 2018-05-17 | 2018-05-17 | A kind of synthesis technology of 5- [2- (3,5- Dimethoxyphenyls) ethyl] -1H- pyrazoles -3- amine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108530361A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111072638A (en) * | 2019-12-13 | 2020-04-28 | 上海工程技术大学 | Method for preparing AZD4547, intermediate and preparation method of intermediate |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107708690A (en) * | 2015-02-27 | 2018-02-16 | 南特生物科学公司 | Pyrimidine derivatives as kinase inhibitors and their therapeutic use |
-
2018
- 2018-05-17 CN CN201810474615.6A patent/CN108530361A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107708690A (en) * | 2015-02-27 | 2018-02-16 | 南特生物科学公司 | Pyrimidine derivatives as kinase inhibitors and their therapeutic use |
Non-Patent Citations (2)
Title |
---|
BO RAM KIM ET AL: "Direct synthesis of pyrazoles from esters using tert-butoxide-assisted C-(C=O) coupling", 《CHEM.COMMUN.》 * |
张岩 等: "《炼钢生产知识》", 30 April 2015, 冶金工业出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111072638A (en) * | 2019-12-13 | 2020-04-28 | 上海工程技术大学 | Method for preparing AZD4547, intermediate and preparation method of intermediate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN115490697B (en) | Asymmetric synthesis method of chiral azaspiro [4,5] -decylamine | |
CN106478504B (en) | Process for the preparation of Roxadustat intermediates | |
CN111646922B (en) | Synthetic method of 2- (4-bromo-2-cyano-6-fluorophenyl) acetic acid | |
CN112062712A (en) | Preparation method of 2- (5-bromo-3-methylpyridin-2-yl) acetic acid hydrochloride | |
CN102304116A (en) | Fluorescein compound and preparation method thereof | |
CN108530361A (en) | A kind of synthesis technology of 5- [2- (3,5- Dimethoxyphenyls) ethyl] -1H- pyrazoles -3- amine | |
CN116693437A (en) | A kind of synthetic method of N-Boc-3-azetidine acetic acid | |
CN102924362B (en) | Preparation method of hexahydro-2-cyclopentyl-pyrryl amine hydrochloride | |
CN111269094B (en) | Preparation method of 2-bromo-1, 3-dimethoxybenzene | |
CN112778220B (en) | Preparation method of benzodiazepine diketone compound D and intermediate thereof | |
CN103058856A (en) | Method for preparing 4-(2,4,5-trifluorophenyl)-5-oxobutyric acid | |
CN102199154A (en) | Novel synthesis method for pyrrole derivatives | |
CN108299269B (en) | A kind of synthetic method of MC-1568 | |
CN114085173B (en) | A kind of preparation method of 2-nitro-4-methylsulfonylbenzaldehyde | |
CN114163417B (en) | Synthesis method of 3-bromodibenzothiophene | |
CN113698392B (en) | A preparation method of Prunster intermediate | |
CN119350232B (en) | A preparation method of 1-(3-bromopyridin-2-yl)ethanone | |
CN107522649A (en) | A kind of 7 ethyl tryptophol method for continuously synthesizing of microwave assisted | |
CN116354814A (en) | Processing technology for improving purity of p-bromomethylphenyl propionic acid | |
CN101851153B (en) | Method for preparing 2-(6'-methoxy-2'-naphthyl) propenol by allylic oxidation | |
CN112694450B (en) | Preparation method of 4-methyl-5-ethoxy oxazole | |
CN110028437B (en) | Method for preparing 2-phenyl-3-aldehyde indole compound under microwave promotion | |
CN102532049B (en) | Method for preparing 2-aldehyde oxazole | |
CN109134472B (en) | Synthesis process of 3- (4-phenoxyphenyl) -1H-pyrazolo [3,4-d ] pyrimidine-4-amine | |
CN107417489A (en) | Method for synthesizing bromo-fused ring aromatic compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180914 |